StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Zhengye Biotechnology's enterprise value was $82.57M on Nov 11, 2026, against $109.52M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$82.57M+23.7%
2025Dec 31, 2025$66.76M–

More Zhengye Biotechnology figures

See a number that looks wrong?